SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-705645
Filing Date
2016-09-09
Accepted
2016-09-08 19:02:02
Documents
5
Period of Report
2016-09-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d245159d8k.htm 8-K 18781
2 EX-1.1 d245159dex11.htm EX-1.1 267125
3 EX-5.1 d245159dex51.htm EX-5.1 7829
4 GRAPHIC g245159g60e14.jpg GRAPHIC 1623
5 GRAPHIC g245159g74w56.jpg GRAPHIC 2676
  Complete submission text file 0001193125-16-705645.txt   301019
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 161877501
SIC: 2834 Pharmaceutical Preparations